Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably pr
Target Price
The average target price of VLG.L is 100 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell